shRNA-mediated knockdown of ATGL consistently impeded the proliferation of NSCLC cells, hepatic cancer cells, colon cancer cells, and prostate cancer cells [[190], [191], [192], [193]]. The gene discussed is PNPLA2; the disease is non-small cell lung carcinoma.